Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers
Haematopoietic stem cell transplantation (HSCT) is the treatment of choice for malignant
haematological diseases. Despite continuous improvements in pre-and post-transplantation …
haematological diseases. Despite continuous improvements in pre-and post-transplantation …
A critical appraisal of extracorporeal photopheresis as a treatment modality for acute and chronic graft-versus-host disease
Although significant advances have been made in the biologic understanding of graft-versus-
host disease (GVHD) and its treatment options, GVHD remains the single most challenging …
host disease (GVHD) and its treatment options, GVHD remains the single most challenging …
Extracorporeal photopheresis (ECP) and the potential of novel biomarkers in optimizing management of acute and chronic graft vs. host disease (GvHD)
M Mankarious, NC Matthews, JA Snowden… - Frontiers in …, 2020 - frontiersin.org
As the use of hematopoietic stem cell transplantation (HSCT) has become a more
widespread and effective treatment for hematological malignant and non-malignant …
widespread and effective treatment for hematological malignant and non-malignant …
Recent insights into extracorporeal photopheresis for graft-versus-host disease
C Del Fante, C Perotti - Expert Review of Clinical Immunology, 2024 - Taylor & Francis
ABSTRACT Introduction Extracorporeal Photopheresis (ECP) may be considered the unique
large-scale cell therapy currently available. It is currently employed mainly as second-line …
large-scale cell therapy currently available. It is currently employed mainly as second-line …
The role of extracorporeal photopheresis in chronic graft-versus-host disease
V Radojcic, MA Pletneva, DR Couriel - Transfusion and Apheresis Science, 2015 - Elsevier
Chronic graft-versus-host disease (GVHD) is the most important cause of late morbidity and
mortality in recipients of allogeneic blood and marrow transplantation. Despite increased …
mortality in recipients of allogeneic blood and marrow transplantation. Despite increased …
Deciphering the mystery: extracorporeal photopheresis in graft-versus-host disease
A Im, SZ Pavletic - Biology of Blood and Marrow Transplantation, 2015 - tctjournal.org
Graft-versus-host disease (GVHD) remains a major challenge for progress in allogeneic
hematopoietic cell transplantation. Steroids continue to be the most effective firstline therapy …
hematopoietic cell transplantation. Steroids continue to be the most effective firstline therapy …
Extracorporeal photopheresis: tolerogenic or immunogenic cell death? Beyond current dogma
D Hannani - Frontiers in immunology, 2015 - frontiersin.org
Extracorporeal photopheresis (ECP) is an autologous cell therapy that is widely used for the
treatment of T cell-mediated diseases. ECP has been FDA-approved for the treatment of …
treatment of T cell-mediated diseases. ECP has been FDA-approved for the treatment of …
[HTML][HTML] Extracorporeal photopheresis in steroid-refractory acute or chronic graft-versus-host disease: results of a systematic review of prospective studies
I Abu-Dalle, T Reljic, T Nishihori, A Antar… - Biology of Blood and …, 2014 - Elsevier
Acute and chronic graft-versus-host disease (GVHD) remain major obstacles for successful
allogeneic hematopoietic cell transplantation. Extracorporeal photopheresis (ECP) …
allogeneic hematopoietic cell transplantation. Extracorporeal photopheresis (ECP) …
[HTML][HTML] Extracorporeal photopheresis in graft-versus-host disease
PA Cantó, JS Caballer, PS Alcaína… - … and cellular therapy, 2023 - Elsevier
Graft-versus-host disease (GVHD) is a major cause of mortality and morbidity following
allogeneic hematopoietic stem cell transplantation. Extracorporeal photopheresis (ECP) …
allogeneic hematopoietic stem cell transplantation. Extracorporeal photopheresis (ECP) …
Response to extracorporeal photopheresis therapy of patients with steroid-refractory/-resistant GvHD is associated with up-regulation of Th22 cells and Tfh cells
M Ni, L Wang, Y Ding, W Gong, S Wang, B Neuber… - Cytotherapy, 2022 - Elsevier
Extracorporeal photopheresis (ECP), a personalized cellular immunotherapy, constitutes a
promising treatment for steroid-refractory/-resistant graft-versus-host disease (SR-GvHD) …
promising treatment for steroid-refractory/-resistant graft-versus-host disease (SR-GvHD) …